CClinicalTrials.gg
CompletedNCT01855958Updated Sep 15, 2017Results posted

Motor Cortex Plasticity and the Effect of Deep Intramuscular Needling Stimulation Therapy (DIMST) in Osteoarthritis Pain

An interventional study of DIMST and Placebo-sham in Knee Osteoarthritis and Chronic Pain, sponsored by Hospital de Clinicas de Porto Alegre. Completed at 1 site in Brazil. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-15.

Sponsored by Hospital de Clinicas de Porto Alegre · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The aim of this study is to evaluate the cortical excitability in pain of knee osteoarthritis (OA), as well as the effect of one session of a kind of electroacupuncture (deep needling intramuscular stimulation therapy - DIMST) in this pain and the cortical excitability after the intervention.

The hypothesis is that cortical excitability is altered in this condition, confirming the findings already described in other chronic pain conditions. The investigators also believe that a session DIMST can reduce pain and alter cortical excitability, restoring its previous activity will occur from chronic pain.

Read the detailed description

Recent developments in the treatment of chronic pain have shown that the primary motor cortex (M1) is an effective target for neural brain stimulation techniques, such as transcranial magnetic stimulation (TMS). Due to these promising initial results, the plasticity of M1 has also been investigated as a potential marker for chronic pain. TMS studies using single or paired pulse shown changes in M1 plasticity in neuropathic pain and fibromyalgia pain compared to healthy subjects. Thus, there is a decrease in the inhibitory activity of chronic pain that can take a state as shown uninhibited by measuring TMS indexed intracortical inhibition (ICI) and cortical silent period (CSP). Based on these experimental data and clinical studies have been focused on the effects of neuromodulation techniques in M1 excitability. The techniques used to stimulate the peripheral nervous system was investigated using different approaches. The DIMST is a therapy applied to treat peripheral chronic syndromes that may have central components such as myofascial pain. During DIMST, the needles are applied to the spinal segment associated with nerve roots dermatome corresponding to the pathology. This treatment can also be effective in the treatment of diseases that have major peripheral components such as OA. OA is a major cause of suffering and disability in the elderly, having an inflammatory component, such as a factor that contributes to the symptoms and progression of the disease. There is evidence that OA could lead to sensitization central and segmental, but these effects on M1 plasticity and other central components are not completely known.

Therefore, researchers proposed to evaluate the plasticity of M1 in this chronic pain condition and also the effect of bottom-up DIMST in pain and cortical excitability.

02

Conditions studied

  • Knee Osteoarthritis
  • Chronic Pain

Keywords

  • Osteoarthritis
  • Electro acupuncture
  • Deep intramuscular stimulation
  • Transcranial Magnetic Stimulation
  • Pain pressure threshold
  • Conditioned pain modulation
  • Clinical trial
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 26 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Hospital de Clinicas de Porto Alegre is the lead sponsor of 450 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women with over 18 years old, with chronic pain because of primary osteoarthritis of the knee.
  • Pain stable for at least three months. Score greater than or equal to 3 cm (0 cm = "no pain" and "worst possible pain" = 10cm) on VAS for pain perception at baseline.
  • No contraindications to electro acupuncture or transcranial magnetic stimulation.
  • Naive in acupuncture treatment.

Exclusion criteria

Exclusion Criteria:

  • Clinically significant or unstable disorder, medical or psychiatric.
  • Presence of neurological or rheumatic comorbidity.
  • Pregnancy.
  • Having performed surgery in the knee to be treated in the last 6 months, or be planning surgery for the next semester.
  • Having performed with corticosteroid infiltration in the last six weeks or are using this.
  • Having performed with hyaluronic acid infiltration.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    DIMST

    The investigators used acupuncture needles with guide tubes (Suzhou Huanqiu Acupuncture Medical Appliance Co. Ltd., 218, China) that were 40 mm in length and 0.25 mm in diameter. The needling in DIMST was applied using an electro acupuncture device (Cosmotron, São Paulo, Brazil) in the dermatomes corresponding to the nerve roots involved in the knee (L1, L2, L3, L4, L5, S1, and S2). DIMST using was administered maintaining a distance from the spinous process line of 2 cm. The anatomic sites of peripheral DIMST were the muscles vastus medialis, rectus femoris, vastus lateralis, tibialis anterior; and the pes anserinus bursae. All subjects received one 30min session using a frequency of 2 Hz.

    Procedure: DIMST

  • Sham comparator
    Placebo-sham

    The investigators used the same electro acupuncture device (Cosmotron, Sao Paulo, Brazil), which was previously set to prevent the current to pass through the electrodes. Subjects were informed that it would be a stimulus of low intensity and high frequency that they probably would not have any sense of it. The electrodes were placed on the same points where the active stimulation was applied while the nerve stimulation unit was left in front of the subject, for 30 minutes. This positioning ensured that the intermittent diode simulating the electrical stimulus was visible and audible.

    Procedure: Placebo-sham

Interventions

  • ProcedureDIMST

    The investigators used electro acupuncture of 2 Hz during 30 minutes.

    Also known as: Paraspinal electro acupuncture.

  • ProcedurePlacebo-sham

    Electro acupuncture with rubber electrodes, without current passing.

    Also known as: Electrostimulation with rubber electrodes.

06

What researchers measure

Primary outcomes

  1. Pain Pressure Threshold (PPT) After Intervention..

    PPT (alone): The patient was instructed to verbally report the perception of pain onset. The investigator assessed PPT using an electronic algometer (J Tech Medical Industries, USA). The device had a 1-cm2 hard-rubber probe, which was applied over structures at L1- L5 dermatome at the knee and at the contralateral forearm. The average values of PPT in kgf/cm2 for three successive readings taken at intervals of 3-5 min were used as the outcomes. # Below, the data after intervention.

    Time frame: Before and within one hour after intervention.

  2. Motor Evoked Potential (MEP) After Intervention.

    Cortical excitability was assessed using a MagPro X100 (MagVenture Company, Lucernemarken, Denmark) and a figure-of-8 coil centered over the left motor cortex (M1). Subjects were seated in a comfortable reclining chair with their arms and hands lying relaxed on the armrests. The investigators measured the resting motor threshold (rMT) of the right first dorsal interosseous (FDI) muscle. The MEPs were recorded by surface electromyography (EMG) using Ag-AgCl cup electrodes in a belly tendon montage. Resting motor threshold (rMT) was defined as the stimulus intensity at which peak-to-peak MEP amplitude of 50 µV (microvolts) was obtained in at least 5 of 10 consecutive trials. MEP was defined as approximately 130% of the rMT or the stimulus intensity at which peak-to-peak MEP amplitude of at least 1 mV was obtained in 10 consecutive trials. The result of the MEP was the average of 10 curves (unconditioned MEP). # Below the data after intervention.

    Time frame: Before and within one hour after intervention.

  3. Conditioned Pain Modulation (CPM) After Intervention.

    PPT during cold water immersion (PPT+CPM): By measuring PPT during cold water immersion, we evaluated the degree to which pain perception is modulated by conditioned pain modulation (CPM) following the presentation of an initial heterotopic noxious stimulus. Subjects immersed their left hands into cold water (zero to 1°C) for 1 minute. During the last 30 seconds of cold-water immersion, the PPT procedure was administered at the right forearm. The temperature was held constant across during the experiment for each subject. # Below the data after intervention.

    Time frame: Before and within one hour after intervention.

Secondary outcomes

  1. Intracortical Inhibition (ICI) After Intervention.

    ICI was evaluated using inter-stimuli intervals (ISIs) of 2 ms with paired-pulse stimulation. The subthreshold stimulus was set at 80% of rMT (conditioning stimulus) , and the suprathreshold test stimulus was set at 130% of rMT. After a randomized protocol, thirty stimuli were assessed using a 2ms interval (ICI), a 12ms interval (ICF) and test-only trials (MEPs). The resulting MEP amplitude was converted into the mean amplitude, and paired-pulse parameters were expressed as the amount of inhibition or facilitation. The calculation result of ICI was done by the ratio of the mean ICI by the mean MEP. # Below the data after intervention.

    Time frame: Evaluated in one day. The cortical excitability before and within an hour after intervention.

  2. Pain Intensity After Intervention.

    The intensity of pain was measured by a 10-cm VAS. VAS scores ranged from no pain (zero) to the worst possible pain possible (10 cm). The pain score on VAS during the last 24 hours was used to classify the subjects into two groups: (1) absence of pain or mild pain (scores equal to or lower than 4 cm) and (2) moderate, intense, or worst possible pain (scores higher than 4 cm). # Below the data after intervention.

    Time frame: Evaluated within twenty four hours before and within one hour after the intervention.

  3. Intracortical Facilitation (ICF) After Intervention.

    ICF was evaluated using an inter-stimuli intervals (ISIs) of 12 ms with paired-pulse and similar parameters for the conditioning and test stimuli. After a randomized protocol, thirty stimuli were assessed using a 2ms interval (ICI), a 12ms interval (ICF) and test-only trials (MEP). The resulting MEP amplitude was converted into the mean amplitude, and paired-pulse parameters were expressed as the amount of inhibition or facilitation. The calculation result of ICF was done by the ratio of the mean ICF by the mean MEP. # Below the data after intervention.

    Time frame: Before and within one hour after intervention.

  4. Cortical Silent Period (CSP) After Intervention.

    To determine the cortical silent period (CSP), subjects were instructed to squeeze the dynamometer using their fingers at 20% of maximal force when a single pulse stimulus (130% rMT) was applied. The result was the average of five consecutive measurements. The CSP was determined by the interval between the stimulus and the motor response elicited in the subject. # Below the data after intervention.

    Time frame: Evaluated before and within one hour after intervention.

07

Results

Posted Sep 22, 2015

Participant flow

Participants were recruited through a call list generated by public means of mass communication in January 2012, and announcements of research in the Department of Pain and Palliative Medicine, Hospital de Clinicas, before and during the study. Throughout the study the members of the list were selected through a telephone interview.

Participant flow — Overall Study
MilestoneDIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With Electrostimulation
Started1313
Completed1213
Not completed10
Withdrew: Withdrawal by subject10

Outcome measures

SecondaryIntracortical Inhibition (ICI) After Intervention.

ICI was evaluated using inter-stimuli intervals (ISIs) of 2 ms with paired-pulse stimulation. The subthreshold stimulus was set at 80% of rMT (conditioning stimulus) , and the suprathreshold test stimulus was set at 130% of rMT. After a randomized protocol, thirty stimuli were assessed using a 2ms interval (ICI), a 12ms interval (ICF) and test-only trials (MEPs). The resulting MEP amplitude was converted into the mean amplitude, and paired-pulse parameters were expressed as the amount of inhibition or facilitation. The calculation result of ICI was done by the ratio of the mean ICI by the mean MEP. # Below the data after intervention.

Time frame:
Evaluated in one day. The cortical excitability before and within an hour after intervention.
Reported as:
Mean · ratio of amplitude (mV).
Intracortical Inhibition (ICI) After Intervention.
ratio of amplitude (mV).DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With Electrostimulation
Intracortical Inhibition (ICI) After Intervention.0.75 ± 0.720.57 ± 0.30
SecondaryPain Intensity After Intervention.

The intensity of pain was measured by a 10-cm VAS. VAS scores ranged from no pain (zero) to the worst possible pain possible (10 cm). The pain score on VAS during the last 24 hours was used to classify the subjects into two groups: (1) absence of pain or mild pain (scores equal to or lower than 4 cm) and (2) moderate, intense, or worst possible pain (scores higher than 4 cm). # Below the data after intervention.

Time frame:
Evaluated within twenty four hours before and within one hour after the intervention.
Reported as:
Mean · cm ( mean).
Pain Intensity After Intervention.
cm ( mean).DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With Electrostimulation
Pain Intensity After Intervention.0.88 ± 1.583.36 ± 3.32
PrimaryPain Pressure Threshold (PPT) After Intervention..

PPT (alone): The patient was instructed to verbally report the perception of pain onset. The investigator assessed PPT using an electronic algometer (J Tech Medical Industries, USA). The device had a 1-cm2 hard-rubber probe, which was applied over structures at L1- L5 dermatome at the knee and at the contralateral forearm. The average values of PPT in kgf/cm2 for three successive readings taken at intervals of 3-5 min were used as the outcomes. # Below, the data after intervention.

Time frame:
Before and within one hour after intervention.
Reported as:
Mean · Kgf / cm2
Pain Pressure Threshold (PPT) After Intervention..
Kgf / cm2DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With Electrostimulation
Pain Pressure Threshold (PPT) After Intervention..8.82 ± 3.006.66 ± 1.67
PrimaryMotor Evoked Potential (MEP) After Intervention.

Cortical excitability was assessed using a MagPro X100 (MagVenture Company, Lucernemarken, Denmark) and a figure-of-8 coil centered over the left motor cortex (M1). Subjects were seated in a comfortable reclining chair with their arms and hands lying relaxed on the armrests. The investigators measured the resting motor threshold (rMT) of the right first dorsal interosseous (FDI) muscle. The MEPs were recorded by surface electromyography (EMG) using Ag-AgCl cup electrodes in a belly tendon montage. Resting motor threshold (rMT) was defined as the stimulus intensity at which peak-to-peak MEP amplitude of 50 µV (microvolts) was obtained in at least 5 of 10 consecutive trials. MEP was defined as approximately 130% of the rMT or the stimulus intensity at which peak-to-peak MEP amplitude of at least 1 mV was obtained in 10 consecutive trials. The result of the MEP was the average of 10 curves (unconditioned MEP). # Below the data after intervention.

Time frame:
Before and within one hour after intervention.
Reported as:
Mean · mV (millivolts).
Motor Evoked Potential (MEP) After Intervention.
mV (millivolts).DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With Electrostimulation
Motor Evoked Potential (MEP) After Intervention.1.14 ± 0.831.12 ± 1.00
SecondaryIntracortical Facilitation (ICF) After Intervention.

ICF was evaluated using an inter-stimuli intervals (ISIs) of 12 ms with paired-pulse and similar parameters for the conditioning and test stimuli. After a randomized protocol, thirty stimuli were assessed using a 2ms interval (ICI), a 12ms interval (ICF) and test-only trials (MEP). The resulting MEP amplitude was converted into the mean amplitude, and paired-pulse parameters were expressed as the amount of inhibition or facilitation. The calculation result of ICF was done by the ratio of the mean ICF by the mean MEP. # Below the data after intervention.

Time frame:
Before and within one hour after intervention.
Reported as:
Mean · ratio of amplitude (mV).
Intracortical Facilitation (ICF) After Intervention.
ratio of amplitude (mV).DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With Electrostimulation
Intracortical Facilitation (ICF) After Intervention.1.20 ± 0.980.78 ± 0.57
SecondaryCortical Silent Period (CSP) After Intervention.

To determine the cortical silent period (CSP), subjects were instructed to squeeze the dynamometer using their fingers at 20% of maximal force when a single pulse stimulus (130% rMT) was applied. The result was the average of five consecutive measurements. The CSP was determined by the interval between the stimulus and the motor response elicited in the subject. # Below the data after intervention.

Time frame:
Evaluated before and within one hour after intervention.
Reported as:
Mean · ms (milliseconds).
Cortical Silent Period (CSP) After Intervention.
ms (milliseconds).DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With Electrostimulation
Cortical Silent Period (CSP) After Intervention.50.93 ± 24.4848.92 ± 22.82
PrimaryConditioned Pain Modulation (CPM) After Intervention.

PPT during cold water immersion (PPT+CPM): By measuring PPT during cold water immersion, we evaluated the degree to which pain perception is modulated by conditioned pain modulation (CPM) following the presentation of an initial heterotopic noxious stimulus. Subjects immersed their left hands into cold water (zero to 1°C) for 1 minute. During the last 30 seconds of cold-water immersion, the PPT procedure was administered at the right forearm. The temperature was held constant across during the experiment for each subject. # Below the data after intervention.

Time frame:
Before and within one hour after intervention.
Reported as:
Mean · Kgf / cm2
Conditioned Pain Modulation (CPM) After Intervention.
Kgf / cm2DIMSTPlacebo-sham
Conditioned Pain Modulation (CPM) After Intervention.12.62 ± 3.479.15 ± 2.17

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
DIMST, Deep Intramuscular Stimulation Therapy—0/13 (0%)0/13 (0%)
Placebo-sham, Rubber Electrodes With Electrostimulation—0/13 (0%)0/13 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With ElectrostimulationTotal
<=18 years000
Between 18 and 65 years8715
>=65 years5611
Age, Continuous
Age, Continuous(years)DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With ElectrostimulationTotal
Mean66.85 ± 7.5363.55 ± 7.5464.50 ± 7.72
Sex: Female, Male
Sex: Female, Male(Participants)DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With ElectrostimulationTotal
Female131326
Male000
Region of Enrollment
Region of Enrollment(participants)DIMST, Deep Intramuscular Stimulation TherapyPlacebo-sham, Rubber Electrodes With ElectrostimulationTotal
Brazil131326
08

Study locations

1 site
  • Hospital de Clínicas de Porto Alegre.
    Porto Alegre, Rio Grande do Sul 90035903, Brazil
09

References and documents

Publications

  • Lefaucheur JP, Drouot X, Menard-Lefaucheur I, Keravel Y, Nguyen JP. Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain. Neurology. 2006 Nov 14;67(9):1568-74. doi: 10.1212/01.wnl.0000242731.10074.3c. PubMed 17101886 ↗
  • Zunhammer M, Eichhammer P, Franz J, Hajak G, Busch V. Effects of acupuncture needle penetration on motor system excitability. Neurophysiol Clin. 2012 Jun;42(4):225-30. doi: 10.1016/j.neucli.2012.02.134. Epub 2012 Mar 6. PubMed 22632870 ↗
  • Lo YL, Cui SL. Acupuncture and the modulation of cortical excitability. Neuroreport. 2003 Jul 1;14(9):1229-31. doi: 10.1097/00001756-200307010-00008. PubMed 12824765 ↗
  • Imamura M, Imamura ST, Kaziyama HH, Targino RA, Hsing WT, de Souza LP, Cutait MM, Fregni F, Camanho GL. Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis. Arthritis Rheum. 2008 Oct 15;59(10):1424-31. doi: 10.1002/art.24120. PubMed 18821657 ↗
  • Schwenkreis P, Scherens A, Ronnau AK, Hoffken O, Tegenthoff M, Maier C. Cortical disinhibition occurs in chronic neuropathic, but not in chronic nociceptive pain. BMC Neurosci. 2010 Jun 11;11:73. doi: 10.1186/1471-2202-11-73. PubMed 20540759 ↗
  • Laste G, Caumo W, Adachi LN, Rozisky JR, de Macedo IC, Filho PR, Partata WA, Fregni F, Torres IL. After-effects of consecutive sessions of transcranial direct current stimulation (tDCS) in a rat model of chronic inflammation. Exp Brain Res. 2012 Aug;221(1):75-83. doi: 10.1007/s00221-012-3149-x. Epub 2012 Jul 3. PubMed 22752510 ↗
  • Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain. 1979 Jun;6(3):305-327. doi: 10.1016/0304-3959(79)90050-2. PubMed 460936 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01855958
Lead sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Associação Fundo de Incentivo à Pesquisa
Responsible party
Sponsor
First posted
May 17, 2013
Start date
Feb 2012
Primary completion
Jun 2012
Completion
Jul 2012
Results posted
Sep 22, 2015
Last update
Sep 15, 2017

Study contacts

Wolnei Caumo, PhD
study director · Federal University of Rio Grande do Sul
Maria L Tarragó, MD
principal investigator · Federal University of Rio Grande do Sul

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion